Home > Newsletters > FDAnews Device Daily Bulletin > Ingen Technologies to Launch Second Generation OxyALERT
FDAnews Device Daily Bulletin
Feb. 3, 2005 | Vol. 2 No. 24
Ingen Technologies to Launch Second Generation OxyALERT
Ingen Technologies, a medical device manufacturer and service provider for medical and consumer markets, has received approval to complete the final phase of development for OxyALERT, the company's flagship product.
OxyALERT is a device that can detect the remaining time of oxygen flow within an oxygen cylinder. A small remote receiver is carried by the patient, caregiver or pilot, and provides a digital LCD display of information regarding the oxygen supply.
CEO and Chairman of Ingen Technologies Scott Sand said, "Our engineers have completed the new design and have started the final production model of OxyALERT. There is no current competition, and our patent was approved with 20 applications."
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.